Trilobio, developer of whole lab automation solutions for advancing biology research, today introduced the first version of its comprehensive robotics, lab equipment and software platform at the ...

Financial writer discusses MGX's gene editing technology, cash runway, and lack of clinical data for potential future ...

Scientists in China have manipulated embryonic stem cells to create laboratory mice with two male parents that managed to ...

Pluristyx has developed a clinical-grade manufacturing process for using a licensed Mad7 gene editing technology to block Human Leukocyte Antigen (HLA) markers expression. Humacyte is optimizing a ...

In this opinion piece, Sylvia Wulf, the Biotechnology Innovation Organization’s interim head of agriculture and environment, ...

Costly biomanufacturing sterilization process are impeding food-tech companies from scaling up — a problem Biosphere is ...

In the realm of genetic engineering and biotechnology, the creation of hybrid animals—organisms that combine genetic material ...

The enthusiasm for the announcement of Stargatethe 500 billion joint venture announced by Trump with the aim of building key ...

Colossal Biosciences is now valued at over $10 billion and is working on ambitious projects to resurrect multiple long ...

A new technology developed at MIT enables scientists to label proteins across millions of individual cells in fully intact 3D tissues with unprecedented speed, uniformity, and versatility.

The CuRVE framework and its implementation in eFLASH mark a significant advancement in volumetric single-cell analysis.